# Biomat USA, Incorporated – FDA Inspection, Feb 18, 2026

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-incorporated/7fa8d789-dfde-4933-9618-63ff88ef8f19
Source feed: FDA_Inspections

> FDA inspection 1303232 of Biomat USA, Incorporated, February 18, 2026. 4 citations under 21 CFR part 606. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1303232
- Company Name: Biomat USA, Incorporated
- Inspection Date: 2026-02-18
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Denver District Office
- Citation Count: 4

## Related Documents

- FDA Inspection 1097379 - 2019-06-19
- FDA Inspection 1049076 - 2018-04-12
- FDA Inspection 981004 - 2016-06-17

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/emily-b-camire/dff5f4c6-bcbe-4ef1-ac0b-1b2701b311ef)

Company: https://www.keypedia.com/companies/biomat-usa-incorporated/757527b1-1bb4-4399-8604-7d57669ceccb

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face
